---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-002061"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2024-01-11T23:59:59+00:00"
generated_at: "2026-06-07T00:35:26.360962+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# AgeX Therapeutics appoints Steven Mintz to Board of Directors, effective Jan 8, 2024

## Summary
- Board of Directors expanded to four members; Steven Mintz appointed as director effective Jan 8, 2024.
- Mintz serves on Audit, Compensation, and Nominating committees. He is a financial consultant and director at Portage Biotech.
- Receives cash fee of $34,331 and options to purchase 63,756 shares of AgeX common stock for 2024 service.
- Additional cash fee of $9,809 for Audit Committee chair role. Fees and options vest quarterly through Dec 31, 2024.

## SEC filing metadata
- accession: 0001493152-24-002061
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2024-01-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315224002061/0001493152-24-002061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315224002061/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-002061
- JSON: https://secwatch.observer/filing/0001493152-24-002061.json
- Plain text: https://secwatch.observer/filing/0001493152-24-002061.txt

## Key facts
- Executive change
  Steven Mintz was appointed as Director at Serina Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On January 8, 2024, the AgeX Board of Directors increased the size of the Board of Directors (the “Board”) to four directors and appointed Steven Mintz as a director to fill the new vacancy on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315224002061/0001493152-24-002061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.